(Q36137980)

English

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein (English)

1 reference

Europe PubMed Central

12 August 2017

2

object named as

M J McElrath

1 reference

Europe PubMed Central

12 August 2017

Robert W Coombs

8

object named as

R W Coombs

1 reference

Europe PubMed Central

12 August 2017

5

object named as

A C Collier

1 reference

Europe PubMed Central

12 August 2017

author name string

E L Cooney

1

1 reference

Europe PubMed Central

12 August 2017

L Corey

3

1 reference

Europe PubMed Central

12 August 2017

S L Hu

4

1 reference

Europe PubMed Central

12 August 2017

D Arditti

6

1 reference

Europe PubMed Central

12 August 2017

M Hoffman

7

1 reference

Europe PubMed Central

12 August 2017

G E Smith

9

1 reference

Europe PubMed Central

12 August 2017

P D Greenberg

10

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 March 1993

1 reference

Europe PubMed Central

12 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

12 August 2017

90

1 reference

Europe PubMed Central

12 August 2017

5

1 reference

Europe PubMed Central

12 August 2017

1882-1886

1 reference

Europe PubMed Central

12 August 2017

Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Expression of the HTLV-III envelope gene by a recombinant vaccinia virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Vaccinia virus expression vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Poxvirus-based vectors as vaccine candidates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Vaccination against SIV infection and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 October 2017

Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Plasma viremia in human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

The persistence of neutralizing antibodies after revaccination against smallpox

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Recombinant Virus Vaccine-Induced SIV-specific CD8 + Cytotoxic T Lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

2 July 2018

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

23 September 2018

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=45984

23 September 2018

Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8446603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160

1 reference

https://pubmed.ncbi.nlm.nih.gov/8446603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8446603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/8446603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/8446603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.90.5.1882

1 reference

Europe PubMed Central

12 August 2017

1993PNAS...90.1882C

0 references

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36137980&oldid=1956790752"